Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05400122
Title Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jennifer Eva Selfridge
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field